Neonatal Infection: Antibiotics for Prevention and Treatment

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: 30 November 2025 | Viewed by 56

Special Issue Editors


E-Mail Website
Guest Editor
Departmental Faculty of Medicine, Saint Camillus International University for Health and Medical Sciences (Unicamillus), Via S. Alessandro 8, 00131 Rome, Italy
Interests: neonatology; neonatal medicine; neonatal sepsis; neonatal resuscitation; neonatal screening

E-Mail
Guest Editor
Neonatal Intensive Care Unit, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio 4, 00165 Rome, Italy
Interests: pregnancy and viral infections
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Infections, particularly bacterial sepsis, represent a leading cause of death and healthcare resource consumption across all age groups. Despite lower mortality rates in infants and children over the past two decades, severe sepsis remains a common cause of death. Premature newborns are particularly vulnerable due to their immature immune systems and the necessity for invasive treatments. Timely antibiotic administration is critical in reducing sepsis mortality in newborns and children. However, diagnostic complexities often result in excessive antibiotic use, leading to the emergence of antibiotic-resistant microorganisms. The tracking of changes in neonatal sepsis prevention and treatment is also hindered by inconsistent definitions that make it difficult to compare data between neonatal centers and between different countries. The diagnosis of organ dysfunction in newborns and preterm infants presents significant challenges due to the absence of baseline values that reflect the temporary alterations associated with the transition from intrauterine to extrauterine life. This complexity further complicates the identification of sepsis in this population. Positive blood cultures, the gold-standard diagnosis method, only confirm infection in 9% of neonates with sepsis.

This Special Issue will address neonatal infections, including bacterial and fungal sepsis, epidemiology, definitions, severity scores, antibiotic use, biomarkers, new antibiotics, antibiotic stewardship, multi-resistance in microorganisms, and challenging infections.

Prof. Dr. Cinzia Auriti
Dr. Maria Paola Ronchetti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neonatal infections
  • neonatal sepsis
  • sepsis definition
  • antibiotics in newborns
  • antibiotic stewardship
  • sepsis biomarkers
  • sepsis diagnosis in newborns
  • epidemiology of neonatal infections
  • fungal invasive infections

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop